In This Article:
Heartland Advisors, an investment management company, released its “Heartland Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund was up 1.97% in the fourth quarter compared to a 1.06% fall for the Russell 2000 Value Index. The fund outperformed the benchmark over the past 1, 3, and 5 years. As in the previous 1, 3, and 5 years, stock selection accounted for almost all of the fourth-quarter outperformance. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024.
Heartland Value Fund highlighted stocks like DENTSPLY SIRONA Inc. (NASDAQ:XRAY), in the fourth quarter 2024 investor letter. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is a global manufacturer and distributor of various dental products and technologies. The one-month return of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was -2.76%, and its shares lost 48.09% of their value over the last 52 weeks. On January 13, 2025, DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stock closed at $18.66 per share with a market capitalization of $3.709 billion.
Heartland Value Fund stated the following regarding DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in its Q4 2024 investor letter:
"One of our worst performers in the quarter was a recent addition, DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Shares of the leading manufacturer of dental equipment and supplies lost more than a quarter of their value after the company voluntarily suspended sales of its Byte Aligners and Impression Kits in late October as it conducts a review of regulatory requirements related to the product.